| Literature DB >> 26912534 |
Kazunori Toyoda1, Masatoshi Koga2, Shoichiro Sato3.
Abstract
The impact of acute therapy for intracerebral hemorrhage is far behind that for acute ischemic stroke. Potential breakthroughs in the management of acute intracerebral hemorrhage are presented. To prevent early hematoma growth, acute blood pressure lowering, emergent hemostatic therapy, and minimally invasive surgery with topical thrombolysis have been attempted. Anti-inflammatory and neuroprotective pharmacotherapies may attenuate perihematomal edema as a surrogate marker for the inflammatory response and improve clinical outcomes after intracerebral hemorrhage. Hyperacute modification of vital parameters, early seizure control, early rehabilitation, and neuroregenerative therapy are other promising strategies in the foreseeable future.Entities:
Keywords: Acute stroke; blood pressure; hemorrhagic stroke; hemostatic therapy; minimally invasive surgery
Mesh:
Year: 2016 PMID: 26912534 DOI: 10.1177/1747493016631559
Source DB: PubMed Journal: Int J Stroke ISSN: 1747-4930 Impact factor: 5.266